期刊文献+

Adoptability and limitation of cancer treatment guidelines: a Chinese oncologist's perspective

Adoptability and limitation of cancer treatment guidelines: a Chinese oncologist's perspective
原文传递
导出
摘要 In recent years, great progress has been made in the treatment of cancer; one of the significant reasons isthe wide adaptation and implementation of standardized treatment based on high-level clinical evidence. Undoubtedly, the advent of guidelines that represent the achievement of the latest and highest quality clinical studies made a significant contribution to the improvement of cancer treatment and management. Aside from cancer patient care, guidelines have also been widely used as standards diagnosis and treatment or primary references in the of other diseases. Numerous guidelines are being enacted each year by a variety of guideline-makers, including national, regional and international academic organizations, medical associations, as well as research institutions and hospitals. In recent years, great progress has been made in the treatment of cancer; one of the significant reasons isthe wide adaptation and implementation of standardized treatment based on high-level clinical evidence. Undoubtedly, the advent of guidelines that represent the achievement of the latest and highest quality clinical studies made a significant contribution to the improvement of cancer treatment and management. Aside from cancer patient care, guidelines have also been widely used as standards diagnosis and treatment or primary references in the of other diseases. Numerous guidelines are being enacted each year by a variety of guideline-makers, including national, regional and international academic organizations, medical associations, as well as research institutions and hospitals.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2012年第5期725-727,共3页 中华医学杂志(英文版)
关键词 cancer treatment guideline CHINESE cancer treatment guideline Chinese
  • 相关文献

参考文献2

二级参考文献40

  • 1Antonio Rollan,Catterina Ferreccio,Alessandra Gederlini,Carolina Serrano,Javiera Torres,Paul Harris.Non-invasive diagnosis of gastric mucosal atrophy in an asymptomatic population with high prevalence of gastric cancer[J].World Journal of Gastroenterology,2006,12(44):7172-7178. 被引量:14
  • 2Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative Radiotherapy Combined with Total Mesorectal Excision for Respectable Rectal Cancer[J] N Engl J Med 2001; 345:638-46.
  • 3Wolpin BM, Meyerhardt JA, Mamon HJ, et al. Adjuvant treatment of colorectal cancer[J]. CA Cancer J Clin 2007; 57:168-85.
  • 4Zheng S, Cai SR. Colorectal Cancer Epidemiology and Prevention Study in China[J]. Chin-German J Clin Oncol 2003; 2:72-76.
  • 5National Comprehensive Cancer Network. NCCN Clinic Practice Guidelines in Oncology Rectal Cancer[M]. Washington: 2008, REC-4.
  • 6Grann A, Feng C, Wong D, et al. preoperative combined modality therapy for clinically respectable UT3 rectal adenocacinoma[J]. Int J Radiat Oncol Biol Phys 2001; 49: 987-95.
  • 7Crane CH, Skibber JM, Birnbaum EH, et al. The Addition of continuous infusion 5-FU to Preoperative Radiation therapy increased tumor response, leading to increases sphincter preservation in locally advanced rectal cancer[J]. Int J Radiat Oncol Biol Phys 2003; 57: 84-9.
  • 8Guillem JG, Chessin DB, Cohen AM, et al. Long- term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer[J]. Ann Surg 2005; 241:829-38.
  • 9Minsky BD, Cohen AM, Kemeny N, et al. Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy[J]. J Clin Oncol 1992; 10: 79-84.
  • 10Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer[J]. N Engl J Med 2006; 355:1114-23.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部